A Study of Glycemic Control in Left Ventricular Assist

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
Type 2 Diabetes MellitusHyperglycemiaHypoglycemia
Interventions
DEVICE

Freestyle Libre 3 Continuous Glucose Monitor (CGM)

Subjects will be provided a Freestyle Libre 3 CGM for monitoring of blood glucose levels throughout participation in the study (approximately 3 months). CGM data will be uploaded to the LibreLink app on a weekly basis for review of glucose control and consultation with a diabetes-trained provider for any values outside of normal ranges. Adjustments to diet and medication therapy (antihyperglycemic therapy) will be made during consultations to improve episodes of hypoglycemia or severe hyperglycemia that were observed.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05933161 - A Study of Glycemic Control in Left Ventricular Assist | Biotech Hunter | Biotech Hunter